Asthma drugs cut risk of CVD
13 September 2007
Some asthma medications might help reduce cardiovascular risk and alleviate asthma symptoms, a US study has shown.
It found patients given low-dose theophylline add-on therapy or the leukotrine receptor antagonist montelukast for asthma had lower cardiovascular disease blood risk factors.
Both drugs are recommended by British Thoracic Society/SIGN guidelines for asthma patients who do not respond to long acting beta-2 agonists.
The study included 489 patients aged from 15-79 years who were diagnosed with asthma, but had an FEV1 greater than 50 per cent.
Dr Steve Holmes, Somerset GP and General Practice Airways Group (GPIAG) chairman said: 'This study looked very much at surrogate markers rather than actual outcomes.'
Comment below and tell us what you thinkAdditional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
